Product Information
RIBAVIRIN 200 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.4507 per EA under NDC 65862020768. Its NADAC has been published 178 times since Nov 28, 2013.
FDA first approved this application on Sep 17, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862020768
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIBAVIRINApproval Type
Generic (ANDA)
FDA Application
ANDA079111FDA Approved
9/17/2009
TE Code
AB
On Market Since
9/17/2009
Pharmacological Classes
Price Statistics
The NADAC for RIBAVIRIN 200 MG TABLET has been published 178 times since Nov 28, 2013, and over the history we have for it it has declined 27.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4507 per EA |
|---|---|
| All-time high | $1.4540 (Mar 12, 2014) |
| All-time low | $0.4507 (Aug 19, 2026) |
| 52-week high | $0.4507 |
| 52-week low | $0.4507 |
| Median price | $0.6705 |
| Average price | $0.6689 |
| Largest weekly change | +134.2% (Jan 22, 2014) |
| Weeks tracked | 178 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ribavirin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIBAVIRIN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIBAVIRIN 200 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.4507 per EA (NDC 65862020768), effective Aug 19, 2026.
How has the price of RIBAVIRIN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIBAVIRIN 200 MG TABLET has declined 27.4%. It has been tracked across 178 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RIBAVIRIN 200 MG TABLET?
Since Nov 28, 2013, the NADAC for RIBAVIRIN 200 MG TABLET has ranged from a low of $0.4507 (Aug 19, 2026) to a high of $1.4540 (Mar 12, 2014), with a median of $0.6705 per EA.
Are there cheaper alternatives to RIBAVIRIN 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of RIBAVIRIN 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RIBAVIRIN 200 MG TABLET?
RIBAVIRIN 200 MG TABLET (NDC 65862020768) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.